Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Testing Conversation Aid in Practice
This update notes that a clinical trial evaluating a conversation aid in breast cancer care sponsored by Beth Israel Deaconess Medical Cente…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]
A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer [Phase 2]
A Phase 2 window-of-opportunity trial in premenopausal patients with ER-positive, HER2-negative early breast cancer comparing giredestrant w…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating TVB-2640 in combination with trastuzumab and paclitaxel or endocrine therapy for HER2-positive meta…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer [Phase 2]
This Phase 2 trial evaluates pembrolizumab in combination with endocrine therapy and palbociclib for postmenopausal patients with newly diag…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer [Phase 3]
Phase 3 trial evaluating hypofractionated radiation therapy after mastectomy to prevent recurrence in stage IIa-IIIa breast cancer has poste…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Culturally Aware AET Non-Initiation Intervention [NA]
This completed study tested a culturally aware intervention to improve initiation and adherence to adjuvant endocrine therapy in breast canc…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Comparison of the Postoperative Analgesic Effects of SPSIPB and TPB in Mastectomy Operations [NA]
A completed clinical trial comparing postoperative analgesia using SPSIPB versus TPB in mastectomy patients, focusing on pain management out…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Preventing Lymphedema in Axillary Lymph Node Dissection [NA]
A Mayo Clinic-sponsored clinical trial investigating prevention of lymphedema after axillary lymph node dissection in breast cancer patients…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) [NA]
A completed trial assessed whether acupuncture could prevent chemotherapy-induced peripheral neuropathy in people with early-stage breast ca…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers [Phase 1]
The first-in-human Phase 1 study of ATX-559, an oral DHX9 inhibitor from Accent Therapeutics, has been terminated; the trial included patien…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) [Phase 2]
Phase II, single-arm trial (SATEEN) evaluating sacituzumab govitecan in combination with trastuzumab for HER2-positive metastatic breast can…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.
A completed clinical trial from Florence Nightingale Hospital Istanbul evaluated machine learning models to predict pathologic complete resp…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
A completed real-world study assessing the effectiveness and tolerability of alpelisib in patients with PIK3CA-mutant breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab [NA]
A clinical trial update from Virginia Commonwealth University evaluating cardiovascular health education via virtual reality for breast canc…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: The Effect of Neoadjuvant Chemotherapy on Physical Functions
This clinical trial update reports on the effect of neoadjuvant chemotherapy on physical functioning in breast cancer patients. The study st…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) [Phase 3]
Phase 3 clinical trial update on evaluating giredestrant versus physician's choice of adjuvant endocrine therapy for estrogen receptor-posit…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
This clinical trial update reports long-term follow-up information for patients enrolled in MC1137, BEAUTY Study for breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration [NA]
A completed clinical trial evaluating how granulocyte colony-stimulating factor influences neutrophil evolution during dense-dose epirubicin…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Opening the Conversation Study [NA]
The Opening the Conversation study sponsored by Oregon State University has completed. The trial focused on breast cancer and gynecologic ca…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors [NA]
The Web-Based Symptom Monitoring and Self-Management Portal (YES) trial for adolescent and young adult breast cancer survivors is currently …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
A completed clinical trial evaluating the effectiveness, safety, and tolerability of anti-HER2 therapies as targeted treatment for ERBB2-pos…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Web-Based Exercise for Neuropathy and Quality of Life in Breast Cancer [NA]
This completed trial evaluated a web-based exercise program to mitigate chemotherapy-induced peripheral neuropathy and improve quality of li…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) [EARLY_Phase 1]
Early-phase window study evaluating intratumoral mitazalimab in breast cancer; the trial is not yet recruiting.